| Literature DB >> 33433914 |
Cédric Tresse1, Marc François-Heude1, Vincent Servajean1, Rubal Ravinder1, Clémence Lesieur1, Lucie Geiben1, Louis Jeanne-Julien2, Vincent Steinmetz1, Pascal Retailleau1, Emmanuel Roulland2, Jean-Marie Beau1,3, Stéphanie Norsikian1.
Abstract
We give a full account of the total synthesis of tiacumicin B (Tcn-B), a natural glycosylated macrolide with remarkable antibiotic properties. Our strategy is based on our experience with the synthesis of the tiacumicin B aglycone and on unique 1,2-cis-glycosylation steps. We used sulfoxide anomeric leaving-groups in combination with a remote 3-O-picoloyl group on the donors that allowed highly β-selective rhamnosylation and noviosylation that rely on H-bond-mediated aglycone delivery. The rhamnosylated C1-C3 fragment was anchored to the C4-C19 aglycone fragment by a Suzuki-Miyaura cross-coupling. Ring-size-selective Shiina macrolactonization provided a semiglycosylated aglycone that was engaged directly in the noviolysation step with a virtually total β-selectivity. Finally, a novel deprotection method was devised for the removal of a 2-naphthylmethyl ether on a phenol, and efficient removal of all the protecting groups provided synthetic tiacumicin B.Entities:
Keywords: antibiotics; cis-glycosylation; glycochemistry; natural products; total synthesis
Year: 2021 PMID: 33433914 DOI: 10.1002/chem.202005102
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236